Presentation is loading. Please wait.

Presentation is loading. Please wait.

Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease  Ronald W Day, MD, John A Hawkins, MD, Edwin C McGough,

Published byGrégoire Morin Modified over 5 years ago

Similar presentations

Presentation on theme: "Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease  Ronald W Day, MD, John A Hawkins, MD, Edwin C McGough,"— Presentation transcript:

1 Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease 
Ronald W Day, MD, John A Hawkins, MD, Edwin C McGough, MD, Kevin L Crezeé, Garth S Orsmond, MD  The Annals of Thoracic Surgery  Volume 69, Issue 6, Pages (June 2000) DOI: /S (00)

2 Fig 1 Ratio of systolic pulmonary and systolic systemic arterial pressures. In comparison to baseline, patients developed a small improvement in the ratio of systolic pulmonary and systolic systemic arterial pressures (systolic PAP/systolic SAP) after the onset of inhaled nitric oxide therapy (∗p = 0.011). However, there were no differences between patient groups at baseline or after 1 hour of observation. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

Download ppt "Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease  Ronald W Day, MD, John A Hawkins, MD, Edwin C McGough,"

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bosentan prevents hypoxia-reoxygenation–induced pulmonary hypertension and improves pulmonary function  Jeffrey M Pearl, MD, Scott A Wellmann, MD, Jerri.

Bosentan prevents hypoxia-reoxygenation–induced pulmonary hypertension and improves pulmonary function  Jeffrey M Pearl, MD, Scott A Wellmann, MD, Jerri.
Inhaled nitric oxide reduces human lung allograft dysfunction

Inhaled nitric oxide reduces human lung allograft dysfunction
Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease  Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease  Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,
Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 
Division of the Main Pulmonary Artery: Suboptimal Palliation for the Patient With a Univentricular Heart  Jeffrey A. Wong, Robert H. Beekman  The Annals.

Division of the Main Pulmonary Artery: Suboptimal Palliation for the Patient With a Univentricular Heart  Jeffrey A. Wong, Robert H. Beekman  The Annals.
Acute Kidney Injury After Surgery for Congenital Heart Disease

Acute Kidney Injury After Surgery for Congenital Heart Disease
Late Results and Reintervention After Aortic Valvotomy for Critical Aortic Stenosis in Neonates and Infants  John A Hawkins, MD, L.LuAnn Minich, MD, Lloyd.

Late Results and Reintervention After Aortic Valvotomy for Critical Aortic Stenosis in Neonates and Infants  John A Hawkins, MD, L.LuAnn Minich, MD, Lloyd.
Immunology and failure of valved allografts in children

Immunology and failure of valved allografts in children
Thomas V Bilfinger, MD, George B Stefano, PhD 

Thomas V Bilfinger, MD, George B Stefano, PhD 
A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients 

A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients 
Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil?  J Ng, S.J. Finney, R Shulman, G.J. Bellingan,

Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil?  J Ng, S.J. Finney, R Shulman, G.J. Bellingan,
Inhaled Nitric Oxide Plus Iloprost in the Setting of Post-Left Assist Device Right Heart Dysfunction  Theofani Antoniou, MD, PhD, Christos Prokakis, MD,

Inhaled Nitric Oxide Plus Iloprost in the Setting of Post-Left Assist Device Right Heart Dysfunction  Theofani Antoniou, MD, PhD, Christos Prokakis, MD,
Ian Adatia, FRCP(C), Andrew M. Atz, MD, Richard A. Jonas, MD, David L

Ian Adatia, FRCP(C), Andrew M. Atz, MD, Richard A. Jonas, MD, David L
Functional assessment of disease-free saphenous vein grafts at redo coronary artery bypass grafting  Thomas V Bilfinger, MD, James A Vosswinkel, MD, Christos.

Functional assessment of disease-free saphenous vein grafts at redo coronary artery bypass grafting  Thomas V Bilfinger, MD, James A Vosswinkel, MD, Christos.
Stanley John, Edwin Ravikumar, Colin N John, Velayudhan V Bashi 

Stanley John, Edwin Ravikumar, Colin N John, Velayudhan V Bashi 
Lung transplantation for primary and secondary pulmonary hypertension

Lung transplantation for primary and secondary pulmonary hypertension
Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease1  Ko Bando, MD, Mark W Turrentine, MD, Palaniswamy.

Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease1  Ko Bando, MD, Mark W Turrentine, MD, Palaniswamy.
Coronary artery operation in patients after breast cancer therapy

Coronary artery operation in patients after breast cancer therapy

Similar presentations

Ads by Google